Vijaya Diagnostic Centre Ltd
NSE:VIJAYA
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
604.35
1 219.65
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Vijaya Diagnostic Centre Ltd
Vijaya Diagnostic Centre Ltd
Cost of Revenue
Vijaya Diagnostic Centre Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Vijaya Diagnostic Centre Ltd
NSE:VIJAYA
|
Cost of Revenue
-₹837.1m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
Dr Agarwal's Eye Hospital Ltd
BSE:526783
|
Cost of Revenue
-₹761.6m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-9%
|
|
|
Thyrocare Technologies Ltd
NSE:THYROCARE
|
Cost of Revenue
-₹1.8B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
|
Cost of Revenue
-₹4.6B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Krsnaa Diagnostics Ltd
NSE:KRSNAA
|
Cost of Revenue
-₹1.5B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-55%
|
CAGR 10-Years
N/A
|
|
|
Metropolis Healthcare Ltd
NSE:METROPOLIS
|
Cost of Revenue
-₹2.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
Vijaya Diagnostic Centre Ltd
Glance View
In the bustling corridors of India's healthcare landscape, Vijaya Diagnostic Centre Ltd. stands as a beacon of precision and reliability. Founded in 1981 in Hyderabad, the company has grown from a single diagnostic center into a formidable network offering a wide array of testing services. With its roots firmly embedded in pathology and radiology, Vijaya combines state-of-the-art technology with a commitment to precision and accuracy, serving millions of patients across numerous locations. Every day, the company's centers buzz with activity as skilled technicians and medical professionals process a vast spectrum of tests and screenings, ranging from routine blood work to advanced imaging services. Vijaya Diagnostic Centre's business model is built upon delivering accurate diagnostic results efficiently, which forms the foundation of its revenue stream. As patients increasingly prioritize quality diagnostics for effective treatment, Vijaya ensures its services remain accessible across its widespread network. With the rising demand for healthcare services in India, paired with an increase in lifestyle-related ailments requiring regular monitoring, Vijaya positions itself strategically by continually expanding its reach and service offerings. Revenues pour in through direct patient payments and collaborations with medical institutions, cementing its role as a critical partner in preventive healthcare and diagnosis-driven wellness strategies.
See Also
What is Vijaya Diagnostic Centre Ltd's Cost of Revenue?
Cost of Revenue
-837.1m
INR
Based on the financial report for Mar 31, 2024, Vijaya Diagnostic Centre Ltd's Cost of Revenue amounts to -837.1m INR.
What is Vijaya Diagnostic Centre Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-16%
Over the last year, the Cost of Revenue growth was -42%. The average annual Cost of Revenue growth rates for Vijaya Diagnostic Centre Ltd have been -14% over the past three years , -16% over the past five years .
You don't have any saved screeners yet